Table 1 Baseline characteristics of the study population. Values are reported as absolute and relative (%) frequencies where applicable. Every OCT-biomarker is displayed in Table 1. Characteristics of each subgroup according to disease stage is displayed

Patients, n

92

92

92

eyes, n (%)

92

92

92

 right

45 (49%)

45 (49%)

45 (49%)

 left

47 (51%)

47 (51%)

47 (51%)

gender, n (%)

 female

53 (58%)

53 (58%)

53 (58%)

 male

39 (42%)

39 (42%)

39 (42%)

Age*, y

 Mean ± SD

71.08 ± 7.31

 Median

71

 Range

50–84

BCVA (LogMar)

0.4

0.2

Disease Stages (median)

3

2

Intraretinal fluid, n

32

5

Retinal Thickness (µm)

488

392

Disease Stage 1 (n)

5

12

Disease Stage 2 (n)

17

12

Disease Stage 3 (n)

6

8

Disease Stage 4 (n)

4

0

CFT (µm)

446.5

383µm

Disease Stage 1 (n)

6

16

Disease Stage 2 (n)

22

30

Disease Stage 3 (n)

36

19

Disease Stage 4 (n)

0

0

CBA, n

30

11

Disease Stage 1 (n)

1

5

Disease Stage 2 (n)

10

15

Disease Stage 3 (n)

19

9

Disease Stage 4 (n)

0

0

EZ/IZ disruption, n

39

25

Disease Stage 1 (n)

1

9

Disease Stage 2 (n)

9

16

Disease Stage 3 (n)

24

14

Disease Stage 4 (n)

5

0

VMT, n

14

0

Disease Stage 1 (n)

1

5

Disease Stage 2 (n)

4

7

Disease Stage 3 (n)

7

2

Disease Stage 4 (n)

2

0